News

Press Release: Leica Biosystems Announces Partnership with Indica Labs to Deliver Integrated Digital Pathology Workflow Solutions for Mutual Customers

Vista, CA – Sep 4, 2022, Leica Biosystems, a cancer diagnostics company and a global leader in workflow solutions, and Indica Labs, the industry-leading provider of computational and image management software in digital pathology, today announced a partnership focused on delivering compatible digital pathology workflow solutions.

Press Release: Leica Biosystems Announces Partnership with Indica Labs to Deliver Integrated Digital Pathology Workflow Solutions for Mutual Customers Read More »

Press Release: Indica Labs Announces Collaboration with The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD) for the Development of an AI-based Algorithm for the Automated Reporting of Lymph Node Status in Colon Cancer

Albuquerque, NM, and Glasgow, Scotland, – 30 August, 2022 – Indica Labs, an industry leader in quantitative digital pathology and image management solutions, and The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD), announced today an agreement to collaborate on the development of an AI-based digital pathology solution for the detection of cancer within lymph nodes from colorectal surgery cases.

Press Release: Indica Labs Announces Collaboration with The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD) for the Development of an AI-based Algorithm for the Automated Reporting of Lymph Node Status in Colon Cancer Read More »

Using Spatial Biology & Advanced Image Analysis Solutions to Decipher Tumor Microenvironment and the Drivers of Cancer Progression by Mass Spectrometry Imaging (MSI) and Imaging Mass Cytometry (IMC)

22 September 2022 | Join us for this 1-hour webinar and learn how MSI and IMC are advancing spatial biology through integration with other imaging and omic analyses

Using Spatial Biology & Advanced Image Analysis Solutions to Decipher Tumor Microenvironment and the Drivers of Cancer Progression by Mass Spectrometry Imaging (MSI) and Imaging Mass Cytometry (IMC) Read More »

Panel discussion: Clustering analysis of highly multiplexed immunofluorescence assays analyzed with the HALO® image analysis platform

13 September 2022 | Join us for this 1.5-hour panel discussion on high dimensional clustering to learn about options for performing clustering analysis and for visualizing high dimensional HALO® Highplex FL data, such as UMAP and t-SNE.

Panel discussion: Clustering analysis of highly multiplexed immunofluorescence assays analyzed with the HALO® image analysis platform Read More »

Press Release: Deep Bio successfully integrates DeepDx® Prostate algorithm into HALO AP® platform from Indica Labs

Seoul, South Korea, and Albuquerque, NM – August 9, 2022 – Deep Bio, a company concentrating on SaMD (Software as a Medical Device) for digital pathology, is offering clinically validated, AI-based DeepDx® algorithms, and Indica Labs, a leading provider of computational pathology software and services, are excited to announce the successful integration of the DeepDx® Prostate algorithm into the HALO AP® platform from Indica Labs.

Press Release: Deep Bio successfully integrates DeepDx® Prostate algorithm into HALO AP® platform from Indica Labs Read More »

Masterclass Webinar: Neurobiology Image Analysis with HALO and HALO AI

29 September 2022 | Join us for this 1-hour webinar for a live demonstration of neurobiology image analysis using HALO® and HALO AI. Dr. Levi Maston will demonstrate the recently released Microglial Activation modules and the Object Colocalization modules for BF and FL analysis in HALO.

Masterclass Webinar: Neurobiology Image Analysis with HALO and HALO AI Read More »

Scroll to Top